Drug Shortage Report for ROCURONIUM BROMIDE INJECTION
Report ID | 236607 |
Drug Identification Number | 02517744 |
Brand name | ROCURONIUM BROMIDE INJECTION |
Common or Proper name | ROCURONIUM BROMIDE INJECTION |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ROCURONIUM BROMIDE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 5mL |
ATC code | M03AC |
ATC description | MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2024-09-04 |
Estimated end date | 2024-09-20 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-09-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2024-09-05 | English | Compare |
v2 | 2024-09-04 | French | Compare |
v1 | 2024-09-04 | English | Compare |
Showing 1 to 3 of 3